Non-small cell lung cancer (NSCLC) patients with higher SENP1 expression show lower rates of complete response, higher partial and non-response rate to chemoradiotherapy (Liu et al., 2018). This evidence concerns the gene SENP1 and non-small cell lung carcinoma.